--- title: "The CNI BIOMEDICINE ETF (159859) saw a net subscription of over 300 million shares yesterday, ranking first among the same underlying assets. Institutions: The innovative industrial chain is expected to continue the overall upward trend in performance in Q1" type: "News" locale: "en" url: "https://longbridge.com/en/news/280236753.md" description: "The CNI BIOMEDICINE ETF (159859) performed outstandingly in trading on March 23, with a net subscription exceeding 300 million shares and a transaction volume of 220 million yuan, making it the leader among similar products. Despite the CNI Biomedicine Index falling by 4.6%, this ETF still attracted capital inflows, demonstrating market confidence in the innovative industry chain. Kaiyuan Securities expects that as the first quarter of 2026 approaches, innovative drugs and related industry chains will continue to maintain an upward trend" datetime: "2026-03-24T01:19:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280236753.md) - [en](https://longbridge.com/en/news/280236753.md) - [zh-HK](https://longbridge.com/zh-HK/news/280236753.md) --- # The CNI BIOMEDICINE ETF (159859) saw a net subscription of over 300 million shares yesterday, ranking first among the same underlying assets. Institutions: The innovative industrial chain is expected to continue the overall upward trend in performance in Q1 Yesterday (March 23), the three major indices opened lower and fell throughout the day, with all dropping over 4%. The National Index of Biomedicine closed down 4.6%, with the constituent stock Dige Pharmaceutical falling 0.31%. Among related ETFs, **the Biomedicine ETF (159859) had a trading volume of 220 million yuan, ranking first among its peers, with a turnover rate exceeding 5.8%**; Wind financial terminal data shows that **the Biomedicine ETF (159859) had over 300 million shares of net subscriptions on that day, ranking first among its peers**. In terms of capital flow, Wind financial terminal data shows that this ETF experienced continuous net inflows last week (March 16 to March 20), accumulating over 70 million yuan. The Biomedicine ETF (159859) closely tracks the Biomedicine Index. The National Index of Biomedicine is based on listed companies in the biomedicine industry within the A-share market, selecting the top 30 stocks as index sample stocks based on a comprehensive ranking of market capitalization and liquidity (if the number is insufficient, stocks are selected based on actual quantity), reflecting the overall operation of the biomedicine industry. This ETF is also equipped with a connection fund (A: 011040, C: 011041). On the news front, according to the Securities Times, in the past two weeks (March 9 to 22, 2026), public fund research data shows that companies in the pharmaceutical and technology sectors, represented by Blue Sail Medical and Hailianxun, received visits from over 40 funds, becoming the most sought-after research targets by fund companies recently. **Kaiyuan Securities** stated that overall, we remain optimistic about innovative drugs and their industrial chain (CXO + research services) as well as national strategic emerging industries such as AI, brain-computer interfaces, and biomanufacturing. With the first quarter performance period of 2026 approaching, the innovative industrial chain is expected to continue the overall upward trend in performance, and orders for preclinical CROs are expected to accelerate growth, making it a key recommendation at this position. ### Related Stocks - [159859.CN](https://longbridge.com/en/quote/159859.CN.md) - [399441.CN](https://longbridge.com/en/quote/399441.CN.md) ## Related News & Research - [Universal Digital Inc. Announces Termination of ETF Partnership Agreement | LFGMF Stock News](https://longbridge.com/en/news/286616540.md) - [Keep Your Portfolio Safe With This Low-Volatility ETF](https://longbridge.com/en/news/286604877.md) - [10X Fund Managers lists 1 million 10X Wealth GOVI ETF units at R 11.63 on JSE](https://longbridge.com/en/news/287065598.md) - [VanEck, Grayscale file fresh BNB ETF amendments as race for next altcoin spot ETF accelerates](https://longbridge.com/en/news/286652991.md) - [BNB ETF Could Be Next Big Crypto Breakthrough, Says Bloomberg Analyst](https://longbridge.com/en/news/286639724.md)